NFKB1 and psoriasis: Previous studies (Xu et al, 2013; Yan et al, 2015) identified miR‐31 as a pro‐inflammatory factor in psoriasis, showing that miR‐31 activated the NF‐kB pathway and thereby increased secretion of a set of cytokines.